Neurol India Home 
 

CORRESPONDENCE
Year : 2011  |  Volume : 59  |  Issue : 5  |  Page : 795-

Authors' reply

AK Kayal, M Goswami, M Das, B Paul 
 Department of Neurology, Gauhati Medical College, Guwahati, Assam, India

Correspondence Address:
A K Kayal
Department of Neurology, Gauhati Medical College, Guwahati, Assam
India




How to cite this article:
Kayal A K, Goswami M, Das M, Paul B. Authors' reply.Neurol India 2011;59:795-795


How to cite this URL:
Kayal A K, Goswami M, Das M, Paul B. Authors' reply. Neurol India [serial online] 2011 [cited 2021 Sep 20 ];59:795-795
Available from: https://www.neurologyindia.com/text.asp?2011/59/5/795/86588


Full Text

Sir,

Thank you for the interest in our article on the clinical spectrum of neurosyphilis. [1],[2] We have used the diagnostic criteria as suggested by Pope and Steiner. [3] Even in the article by Workoswki et al.,[4] it is mentioned that "The venereal disease research laboratory in cerebrospinal fluid (CSF VDRL), which is highly specific but insensitive, is the standard serologic test for CSF. When reactive in the absence of substantial contamination of CSF with blood, it is considered diagnostic of neurosyphilis". Therefore the laboratory diagnosis of neurosyphilis usually depends on various combinations of reactive serologic test results, CSF cell count or protein; and a reactive CSF VDRL with or without clinical manifestations. In our series blood VDRL and CSF VDRL was done in all the patients. In addition blood TPHA was also done in 14 of 16 patients and all these patients were positive. CSF fluorescent treponemal antibody - absorbtion, CSF TPHA though sensitive are not routinely available.

References

1Joob B, Wiwanitkit V. Clinical spectrum of neurosyphilis in North East India. Neurol India 2011;59:794-5.
2Kayal AK, Goswami M, Das M, Paul B. Clinical spectrum of neurosyphilis in North East India. Neurol India 2011;59:344-50.
3Pope V, Steiner BM. Syphilis. In: Hiscox JA, editor. Topley and Wilson's microbiology and microbial infection, 10 th ed. New York: Wiley and Blackwell; 2007. p. 1838-64.
4Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.